Unknown

Dataset Information

0

AP-1 Inhibition by SR 11302 Protects Human Hepatoma HepG2 Cells from Bile Acid-Induced Cytotoxicity by Restoring the NOS-3 Expression.


ABSTRACT: The harmful effects of bile acid accumulation occurring during cholestatic liver diseases have been associated with oxidative stress increase and endothelial nitric oxide synthase (NOS-3) expression decrease in liver cells. We have previously reported that glycochenodeoxycholic acid (GCDCA) down-regulates gene expression by increasing SP1 binding to the NOS-3 promoter in an oxidative stress dependent manner. In the present study, we aimed to investigate the role of transcription factor (TF) AP-1 on the NOS-3 deregulation during GCDCA-induced cholestasis. The cytotoxic response to GCDCA was characterized by 1) the increased expression and activation of TFs cJun and c-Fos; 2) a higher binding capability of these at position -666 of the NOS-3 promoter; 3) a decrease of the transcriptional activity of the promoter and the expression and activity of NOS-3; and 4) the expression increase of cyclin D1. Specific inhibition of AP-1 by the retinoid SR 11302 counteracted the cytotoxic effects induced by GCDCA while promoting NOS-3 expression recovery and cyclin D1 reduction. NOS activity inhibition by L-NAME inhibited the protective effect of SR 11302. Inducible NOS isoform was no detected in this experimental model of cholestasis. Our data provide direct evidence for the involvement of AP-1 in the NOS-3 expression regulation during cholestasis and define a critical role for NOS-3 in regulating the expression of cyclin D1 during the cell damage induced by bile acids. AP-1 appears as a potential therapeutic target in cholestatic liver diseases given its role as a transcriptional repressor of NOS-3.

SUBMITTER: Gonzalez-Rubio S 

PROVIDER: S-EPMC4973998 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature

altmetric image

Publications

AP-1 Inhibition by SR 11302 Protects Human Hepatoma HepG2 Cells from Bile Acid-Induced Cytotoxicity by Restoring the NOS-3 Expression.

González-Rubio Sandra S   Linares Clara I CI   Aguilar-Melero Patricia P   Rodríguez-Perálvarez Manuel M   Montero-Álvarez José L JL   de la Mata Manuel M   Ferrín Gustavo G  

PloS one 20160804 8


The harmful effects of bile acid accumulation occurring during cholestatic liver diseases have been associated with oxidative stress increase and endothelial nitric oxide synthase (NOS-3) expression decrease in liver cells. We have previously reported that glycochenodeoxycholic acid (GCDCA) down-regulates gene expression by increasing SP1 binding to the NOS-3 promoter in an oxidative stress dependent manner. In the present study, we aimed to investigate the role of transcription factor (TF) AP-1  ...[more]

Similar Datasets

| S-EPMC7227015 | biostudies-literature
| S-EPMC2837105 | biostudies-literature
| S-EPMC3564157 | biostudies-literature
2010-06-11 | E-GEOD-2572 | biostudies-arrayexpress
| S-EPMC2715238 | biostudies-literature
| S-EPMC3594677 | biostudies-literature
| S-EPMC5428050 | biostudies-literature
2006-04-26 | GSE2572 | GEO
| S-EPMC5012526 | biostudies-literature
| S-EPMC4964392 | biostudies-literature